Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-05-16
2006-05-16
Housel, James C. (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C424S184100, C424S229100, C424S186100
Reexamination Certificate
active
07045598
ABSTRACT:
The present invention provides recombinant and/or isolated infectious laryngotracheitis virus glycoproteins, including gD, gl, gG and gE.
REFERENCES:
patent: 4769331 (1988-09-01), Roizman et al.
patent: 4877737 (1989-10-01), Shih
patent: 4980162 (1990-12-01), Honda et al.
patent: 5047237 (1991-09-01), Cochran et al.
patent: 5182210 (1993-01-01), Binns et al.
patent: 5187087 (1993-02-01), Sondermeijer et al.
patent: 5223424 (1993-06-01), Cochran et al.
patent: 5231023 (1993-07-01), Morgan
patent: 5240703 (1993-08-01), Cochran et al.
patent: 5252717 (1993-10-01), Velicer
patent: 5279965 (1994-01-01), Keeler, Jr.
patent: 5310671 (1994-05-01), Binns et al.
patent: 5869312 (1999-02-01), Cochran et al.
patent: 5928648 (1999-07-01), Cochran
patent: 6033904 (2000-03-01), Cochran et al.
patent: 6123949 (2000-09-01), Cochran et al.
patent: 6221361 (2001-04-01), Cochran et al.
patent: 6328975 (2001-12-01), Cochran et al.
patent: 6497882 (2002-12-01), Cochran et al.
patent: 2050850 (1992-03-01), None
patent: 0 431 668 (1991-06-01), None
patent: 0 473 210 (1992-03-01), None
patent: 0 477 056 (1992-03-01), None
patent: WO 87/04429 (1987-07-01), None
patent: WO 88/07088 (1988-09-01), None
patent: WO 89/01040 (1989-02-01), None
patent: WO 90/02802 (1990-03-01), None
patent: WO 90/02803 (1990-03-01), None
patent: WO 91/02053 (1991-02-01), None
patent: WO 92/01040 (1992-01-01), None
patent: WO 92/02053 (1992-02-01), None
patent: WO 92/02802 (1992-02-01), None
patent: WO 92/03547 (1992-03-01), None
patent: WO 92/03554 (1992-03-01), None
patent: WO 93/14194 (1993-07-01), None
patent: WO 95/03070 (1995-02-01), None
BLAST Alignment, residues 58-410 of SEQ ID No.: 11 with GenBank Accession AAA98925.
Andreasen, J., et al., “Studies of infectious laryngotracheitis vaccines: Immunity in broilers,”Avian Diseases33:516-23 (1989).
Andreasen, J., et al., “Studies of infectious laryngotracheitis vaccines: Immunity in vayers,”Avian Diseases33:524-30 (1989).
Andreasen, J., et al., “Reproducibility of a virus-neutralization test for infections laryngotracheitis virus,”Avian Diseases34:185-194.
Andreasen, J., et al., “Differentiation of vaccine strains and Georgia field isolates of infectious laryngotracheitis virus by their restriction endonuclease fragment patterns,”Avian Diseases34:646-56(1990).
Cantello, J., et al., “Isolation of a Marek's Disease Virus (MDV) recombinant containing the IacZ gene ofEscherichia coli, ” J. Gen. Virology65:1584-1588.
Colle, et al., “Open reading frames encoding a protein kinase, homolog of glycoprotein gX of pseudorabies virus and a novel glycoprotein map within the unique short segment of equine herpesvirus type 1.,”Virology188:545-57 (1992).
Davison, S., et al., “Laryngotracheitis in chickens: The length of the preinfectious periods,”Avian Diseases33:18-23 (1989).
Davison, S., et al., “Laryngotracheitis in chickens: Infections studies and the efficacy of a tissue-culture vaccine in chicks less than four weeks old,”Avian Diseases33:24-29 (1989).
Finkelstein, A., et al., “Live recombinant vaccines for poultry,”Trends in Biotechnology7:273-77 (1989).
Griffin, A., et al., “The neucleotide sequence of the glycoprotein gB gene of infectious laryntracheitis virus: Analysis and evolutionary relationship to the homologous gene from other herpesviruses,”J. Gen. Virology72:393-98 (1991).
Griffin, A., et al., The complete sequence of the capsid p40 gene from infectious laryngotracheitis virus,Nucleic Acids Res. 18:3664 (1991).
Griffin, A., et al., “Identification of 21 genes of infectious laryngotracheitis virus random sequencing of genomic DNA,”J. Gen. Virology70:3085-89 (1989).
Griffin, A., “Analysis of the nucleotide sequence of DNA from the region of the thymidine kinase gene of infectious laryngotracheitis virus: Potential evolutionary relationships between the herpesvirus subfamilies,”J. Gen. Virology71:841-50 (1990).
Griffin, H., “AttenuatedSalmonellaas live vaccines: Prospects for multivalent poultry vaccines,”World's Poultry Science Journal47:131-40 (1991).
Guo, et al., “Construction of recombinant avian infectious laryngotracheitis virus express the β-galactosidase gene and DNA sequencing of the insertion region,”Virology202:771-81 (1994).
Guy, J., et al., “Virulence of infectious laryngotracheitis viruses: Comparison of modified-live vaccine viruses and North Carolina field isolates,”Avian Diseases34:106-13 (1990).
Guy, J., et al., “Increased virulence of modified-live infections laryngotracheitis vaccine virus following bird-to-bird passage,”Avian Diseases35:348-55 (1991).
Guy, J., et al., “Restriction endonuclease analysis of infections laryngotracheitis viruses: Comparison of modified-live vaccine and North Carolina field isolates,”Avian Diseases33:316-23 (1989).
Hanson, et al., Disease of Poultry, Ninth Edition, M.S. Hofstad Ed., pp. 485-495, Iowa State University Press (1991).
Hughes, et al., “Latency and reactivation of infectious laryngotracheitis vaccine virus,”Arch. Virol.121:213-18 (1991).
Izuchi, et al., “Studies on a live virus vaccine against infectious laryngotracheitis of chickens, I. Biological properties of attenuated strain C7,”Avian Diseases27:918-926. (1983).
Johnson, M., et al., “Gallid herpesvirus 1 (infectious laryngotracheitis virus): Cloning and physical maps of the SA-2 strain,”Arch Virol.119:181-198 (1991).
Johnson, et al., “Sequence characteristics of a gene in infections laryngotracheitis virus homologous to glycoprotein D of herpes simplex virus,”The Journal of Sequencing and Mapping5:191-94 (1995).
Johnson, et al., “Nucleotide sequence of infectious laryngotracheitis virus (gallid herpesvirus 1) ICP4 gene,”Virus Research35:193-204 (1995).
Johnson, et al., “Molecular evolution of infectious laryngotracheitis virus (ILTV; gallid herpesvirus 1): An ancient example of the Alphaherpesviridae?”Veterinary Microbiology46:221-31 (1995).
Keam, L., et al., “Detection of infectious laryngotracheitis virus in chickens using a non-radioactive DNA probe,”Avian Diseases35:257-262 (1991).
Keeler, C., et al., “Identification of the thymidine kinase gene of infectious laryngotracheitis virus,”Avian Diseases35:920-929 (1991).
Key, D., et al., Abstract From the 65thNortheast Conference on Avian Disease, Jun. 9-11, University of Delaware, Newark, Delaware (1993).
Kingsley, et al., Abstract From the 65thNortheastern Conference on Avian Diseases, Jun. 9-11, University of Delaware, Newark, Delaware (1993).
Kongsuwan, K., et al., “Nucleotide sequence of the gene encoding infectious laryngotracheitis virus glycoprotein B,”Virology184:404-410 (1991).
Kongsuwan, K., et al., “Use of lambda gtil and monoclonal antibodies to map the gene for the 60,000 Dalton glycoprotein of infectious laryngotracheitis virus,”Virus Genes7:297-303 (1993).
Kongsuwan, K., et al., “Identification on an infectious laryngotracheitis virus gene encoding an immunogenic protein with a predicted M(r) of 32 kilodaltons,”Virus Research29:125-140 (1993).
Kotiw, M., et al., “Differentiation of infectious laryngotracheitis virus strain using restriction endonucleases,”Avian Diseases26:718-731 (1982).
Kotiw, M., et al., “Differentiation between virulent and avirulent strains of infectious laryngotracheitis virus by DNA: DNA hybridization using a cloned DNA marker,”Vet. Microbiology11:319-330 (1986).
Leib, D. et al., “Restriction endonuclease patterns of some European and American isolates of avian infectious laryngotracheitis virus,”Avian Diseases30:835-837 (1986).
Leib, D., et al., “Genome isomerism in two alphaherpesviruses: Herpesvirus Saimiri-1 (Herpesvirus tamarinus) and avian infectious laryngotracheitis virus,”Arch Virology93:287-294 (1987).
Nazerian, et a
Cochran Mark D.
Wild Martha A.
Housel James C.
Lucas Zacariah
Schering-Plough Animal Health
LandOfFree
Recombinant infectious laryngotracheitis virus and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant infectious laryngotracheitis virus and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant infectious laryngotracheitis virus and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3607582